CYP For Sale @ $10 to $20, page-98

Just conversed with Dr.Macdonald, who's still on the road at the moment and has had a hectic week.

He cleared up some of the crazy rumours flying around regarding numbers being pulled out of the sky for future share price.

"... THE MULTIPLES YOU HAVE MENTIONED WERE TAKEN OUT OF CONTEXT IN A RECENT ARTICLE. SOMEHOW THE GENERALISED COMMENT THAT SUCH MULTIPLES ARE SOMETIMES ACHIEVED IN BIOTECH-BIG PHARMA TRANSACTIONS WAS TAKEN TO MEAN THAT THIS WAS DIRECTLY RELEVANT TO CYNATA’S SITUATION.

WE HAVE OFTEN STATED THAT OUR BUSINESS STRATEGY IS TO SEEK CORPORATE PARTNERSHIPS FOR THE FURTHER DEVELOPMENT AND COMMERCIALISATION OF THE CYMERUS TECHNOLOGY. ON THE BACK OF THE EXCELLENT ACHIEVEMENTS SO FAR IN OUR MANUFACTURING VALIDATION WE WILL NOW ENGAGE IN A VIGOROUS BUSINESS DEVELOPMENT CAMPAIGN TO ENSURE THE BEST ACHIEVABLE OUTCOME.

WE HAVE NEITHER PROVIDED ANY GUIDANCE ON WHEN (OR IF) A DEAL(S) MIGHT HAPPEN, NOR ANY GUIDANCE ON THE POSSIBLE FINANCIAL TERMS. THERE ARE HOWEVER MANY EXAMPLES OF BIOTECH-PHARMA DEALS IN THE PUBLIC DOMAIN.

IT IS SALIENT TO NOTE THAT ON THE BACK OF THE DEAL WITH CEPHALON, MESOBLAST’S SHARE PRICE WENT FROM ~$2 TO ~$9 DURING THE 12 MONTHS FROM MID 2010 TO 2011. HERE IS A LINK TO A RECENT DEAL INVOLVING A PRE-CLINICAL ASSET; I TRUST YOU WILL AGREE THIS WAS A PRETTY SPECTECULAR OUTCOME: http://finance.yahoo.com/news/bristol-myers-squibb-expand-immuno-130000160.html ..."

Hope this is helpful to anyone, this isn't meant to be financial advice, just simply passing on what I can from conversations with the company. Always do your own research (reading HotCopper comments doesn't count as research!!!)

TheArchitect

(I have permission to relay and post the information above onto a public forum)